Published in Women's Health Weekly, June 16th, 2005
Gardasil is an investigational vaccine designed to prevent infection from four common HPV types - 16, 18, 6, and 11 - and related cervical cancer, cervical precancers, and genital warts. These data from a phase III study of Gardasil were presented for the first time at the annual meeting of the European Society of Pediatric Infectious Diseases (ESPID). This is the first trial to evaluate the immune responses and tolerability among young...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly